Bethea ED, Chen Q, Hur C, et al. Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals. AASLD 2017, abstract 24.
Vedolizumab versus adalimumab voor matige tot ernstige colitis ulcerosa
okt 2019 | IBD